| (HKD) | Jun 2020 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 9966.HK returned -24.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -17.3% |
| 1 year | -24.8% |
| 5 years | -59.4% |
| All-time high | $24.85 (Jun 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in 9966.HK would be worth today ›No. Alphamab Oncology has not paid a dividend in the past 12 months.
Alphamab Oncology is part of the Healthcare sector.
Alphamab Oncology has a market cap of 7.87B HKD, based on the latest quote.
Alphamab Oncology is scheduled to report earnings on Aug 27, 2026.
